More articles from METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

You have access
CC-115, a Dual Mammalian Target of Rapamycin/DNA-Dependent Protein Kinase Inhibitor in Clinical Trial, Is a Substrate of ATP-Binding Cassette G2, a Risk Factor for CC-115 Resistance
Jenny Beebe and Jian-Ting Zhang

Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 320-326; DOI: https://doi.org/10.1124/jpet.119.258392
You have access
Direct Measurement of Kinetic Parameters of ABCG2-Dependent Transport of Natural Flavonoids Using a Fluorogenic Substrate
Michal Rozanski, Maciej Studzian and Lukasz Pulaski

Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 309-319; DOI: https://doi.org/10.1124/jpet.119.261347
You have access
Sampling site has a critical impact on PBPK modeling
Weize Huang and Nina Isoherranen

Journal of Pharmacology and Experimental Therapeutics October 11, 2019, jpet.119.262154; DOI: https://doi.org/10.1124/jpet.119.262154
Open Access
Absence of Pharmacokinetic Interactions between the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate
Nicholas Steven Jones, Helen Winter, Tamiko R. Katsumoto, Marilyn Florero, Elaine Murray, Helen Walker, Nand Singh and Leslie W. Chinn

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 202-207; DOI: https://doi.org/10.1124/jpet.119.257089
You have access
Effect of Pregnancy on Paroxetine-Induced Adiposity and Glucose Intolerance in Mice
Weibin Zha, Tao Hu, Mary F. Hebert and Joanne Wang

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 113-120; DOI: https://doi.org/10.1124/jpet.118.255380
Open Access
Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor
Tetsuya Taniguchi, Naoki Ashizawa, Koji Matsumoto, Ryo Saito, Keisuke Motoki, Miku Sakai, Noriko Chikamatsu, Chiharu Hagihara, Masamichi Hashiba and Takashi Iwanaga

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 162-170; DOI: https://doi.org/10.1124/jpet.119.259341
You have access
Simultaneous Assessment of Hepatic Transport and Metabolism Pathways with a Single Probe Using Individualized PBPK Modeling of ¹⁴CO₂ Production Rate Data
Yoko Franchetti and Thomas D. Nolin

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 151-161; DOI: https://doi.org/10.1124/jpet.119.257212
Open Access
Mechanistic and Quantitative Understanding of Pharmacokinetics in Zebrafish Larvae through Nanoscale Blood Sampling and Metabolite Modeling of Paracetamol
Rob C. Van Wijk, Elke H.J. Krekels, Vasudev Kantae, Anita Ordas, Thijs Kreling, Amy C. Harms, Thomas Hankemeier, Herman P. Spaink and Piet H. van der Graaf

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 15-24; DOI: https://doi.org/10.1124/jpet.119.260299
You have access
In Vitro and In Silico Analyses of the Inhibition of Human Aldehyde Oxidase by Bazedoxifene, Lasofoxifene, and Structural Analogues
Shiyan Chen, Karl Austin-Muttitt, Linghua Harris Zhang, Jonathan G. L. Mullins and Aik Jiang Lau

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 75-86; DOI: https://doi.org/10.1124/jpet.119.259267
You have access
A pharmacokinetic natural product-disease-drug interaction: a double hit of silymarin and nonalcoholic steatohepatitis on hepatic transporters in a rat model
Michelle L Montonye, Dan-Dan Tian, Tarana Arman, Katherine D Lynch, Bruno Hagenbuch, Mary F Paine and John D Clarke

Journal of Pharmacology and Experimental Therapeutics August 16, 2019, jpet.119.260489; DOI: https://doi.org/10.1124/jpet.119.260489

Main menu

User menu

Search

More articles from METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Pages

Navigate

More Information

ASPET's Other Journals